HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?

Abstract
Inhibition of voltage-gated L-type calcium channels by organic calcium channel blockers is a well-established pharmacodynamic concept for the treatment of hypertension and cardiac ischemia. Since decades these antihypertensives (such as the dihydropyridines amlodipine, felodipine or nifedipine) belong to the most widely prescribed drugs world-wide. Their tolerability is excellent because at therapeutic doses their pharmacological effects in humans are limited to the cardiovascular system. During the last years substantial progress has been made to reveal the physiological role of different L-type calcium channel isoforms in many other tissues, including the brain, endocrine and sensory cells. Moreover, there is accumulating evidence about their involvement in various human diseases, such as Parkinson's disease, neuropsychiatric disorders and hyperaldosteronism. In this review we discuss the pathogenetic role of L-type calcium channels, potential new indications for existing or isoform-selective compounds and strategies to minimize potential side effects.
AuthorsJörg Striessnig, Nadine J Ortner, Alexandra Pinggera
JournalCurrent molecular pharmacology (Curr Mol Pharmacol) Vol. 8 Issue 2 Pg. 110-22 ( 2015) ISSN: 1874-4702 [Electronic] United Arab Emirates
PMID25966690 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Protein Isoforms
  • Protein Subunits
Topics
  • Antihypertensive Agents (classification, pharmacology)
  • Brain (drug effects, metabolism, physiopathology)
  • Calcium Channel Blockers (classification, pharmacology)
  • Calcium Channels, L-Type (genetics, metabolism)
  • Humans
  • Ion Channel Gating (drug effects, genetics, physiology)
  • Models, Biological
  • Mutation
  • Protein Isoforms (antagonists & inhibitors, genetics, metabolism)
  • Protein Subunits (antagonists & inhibitors, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: